Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;25(1):33–37. doi: 10.1002/clc.4950250109

Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris

Ryan V Cantwell 1, Ronnier J Aviles 1, Johannes Bjornsson 2, R Scott Wright 3,, William K Freeman 3, Jae K Oh 3, James D Hoyer 2, Svetomir Markovic 1, Allan S Jaffe 2,3
PMCID: PMC6653946  PMID: 11808838

Abstract

We present the case of a 43‐year‐old male who was initially evaluated for angina pectoris and dyspnea. His CK, CK‐MB, and cTnI were all elevated following a blood transfusion and he underwent coronary arteriography, which demonstrated no luminal obstructions. After several months, he was transferred to Mayo Clinic where diagnoses of fulminant cardiac amyloidosis and systemic multiple myeloma were established. The cTnI remained elevated despite normalization of the CK and CK‐MB. Despite aggressive treatment, the patient died. Postmortem analysis demonstrated amyloid cardiac deposition including involvement of the coronary microvasculature. Electron microscopy revealed myocyte compression injury from amyloid infiltration. We believe this is the first report of elevated troponin I in a patient with cardiac amyloidosis. The electron microscopy in our case confirms cardiac damage as the mechanism for cTnI elevation. This observation strengthens our knowledge about the specificity of cTnI for the detection of cardiac injury.

Keywords: troponin, cardiac amyloidosis, angina pectoris, myocardial infarction

Full Text

The Full Text of this article is available as a PDF (255.7 KB).

References

  • 1. Apple FS, Falahati A, Paulsen PR, Miller EA, Sharkey SW: Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem 1997; 43(11): 2047–2051 [PubMed] [Google Scholar]
  • 2. Adams J, Scheckman KB, Landt J, Ladenson JH, Jaffe AS: Comparable detection of cute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 4017:1291–1295 [PubMed] [Google Scholar]
  • 3. Adams JE, Bodor GS, Davila‐Roman VG, Delinez JA, Apple FS, Landenson JM, Jaffe AS: Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993; 88:101–106 [DOI] [PubMed] [Google Scholar]
  • 4. Coudrey L: The troponins. Arch Intern Med 1998; 158:1173–1180 [DOI] [PubMed] [Google Scholar]
  • 5. Tanasijevic MJ, Cannon CP, Antman EM: The role of cardiac troponin‐I (cTnI) in risk stratification of patients with unstable coronary artery disease. Clin Cardiol 1999; 22:13–16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Galvani M, Ottani F, Ferrinin D, Ladenson JH, Destro A, Baccos D, Rusticali F, Jaffe AS: Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95:2053–2059 [DOI] [PubMed] [Google Scholar]
  • 7. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E: Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342–1349 [DOI] [PubMed] [Google Scholar]
  • 8. McLaurin MD, Apple FS, Herzog CA, Sharkey SW: Cardiac troponin I, T, and CK‐MB in chronic hemodialysis patients. Circulation 1995; 92:I80 [Google Scholar]
  • 9. Trinquier S, Flecheux O, Bullenger M, Castex F. Highly specific immunoassay for cardiac troponin I assessed in non‐infarct patients with chronic renal failure or severe polytrauma. Clin Chem 1995; 41:1675–1676 [PubMed] [Google Scholar]
  • 10. Missov E, Calzolari C, Pau B: Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96(9): 2953–2958 [DOI] [PubMed] [Google Scholar]
  • 11. Missov E, Calzolari C, Davy JM, Leclercq F, Rossi M, Pau B: Cardiac troponin I in patients with hematologic malignancies. Coron Art Dis 1997; 8(8–9): 537–541 [PubMed] [Google Scholar]
  • 12. Capone R, Amsterdam EA, Mason DT, Zelis R: Systemic amyloi‐dosis, functional coronary insufficiency, and autonomic impairment. Ann Intern Med 1972; 76:599–603 [DOI] [PubMed] [Google Scholar]
  • 13. Cueto‐Garcia L, Tajik AJ, Kyle RA, Edwards WD, Wood DL, Seward JB: Echocardiographic features of amyloid ischemic heart disease. Am J Cardiol 1985; 55:606–607 [DOI] [PubMed] [Google Scholar]
  • 14. Smith RRL, Hutchins GM: Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol 1979; 44:413–417 [DOI] [PubMed] [Google Scholar]
  • 15. Narang R, Chopra P, Wasir HS: Cardiac amyloidosis presenting as ischemic heart disease. Cardiology 1993; 82:294–300 [DOI] [PubMed] [Google Scholar]
  • 16. Saltissi S, Kertes PJ, Julian DG: Primary cardiac amyloidosis in a young man presenting with angina pectoris. Br Heart J 1984; 52:233–236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Wright JR, Calkins E: Amyloid in the aged heart: Frequency and clinical significance. J Am Geriatr Soc 1975; 23:97–103 [DOI] [PubMed] [Google Scholar]
  • 18. Tunstall‐Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A: Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case‐fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90(1): 583–612 [DOI] [PubMed] [Google Scholar]
  • 19. Antman EM, Grudzien C, Mitchell RN, Sacks DB: Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am Heart J 1997; 133(5): 596–598 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES